speb/financial-data huggingface dataset:
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -2360000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -2360000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 48180000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 15890000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 6363310000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -761930000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 0.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 8060480000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 218460000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 225450000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 693780000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 69070000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Normalized Income: -249408000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 34680000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Operating Income: -442220000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 5519290000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 616200000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 52640000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 216540000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 359980000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -424150000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 615500000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 218500000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 32960000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 846360000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 82720000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 5600400000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 43890000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 1266630000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Other Special Charges: -357700000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Payables: 1538340000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 356880000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Preferred Securities Outside Stock Equity: 59940000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 608840000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Pretax Income: 14770000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -64980000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -3506230000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -828760000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1138240000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 2689520000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 367110000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 33960000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 33960000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -2360000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 110030000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 7883430000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 4235050000.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 66830000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 285240000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 580500000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 61250746.00
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 0.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Special Income Charges: 306130000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 8420460000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 8060480000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 101862000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Tax Provision: 29820000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
PANACEABIO.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -25060000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Total Assets: 12408210000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 8570460000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Total Debt: 150000000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 8382250000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Total Expenses: 5961510000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 4025960000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 7553540000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 936140000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 9080000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 1300000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 339540000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 339540000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Work In Process: 174780000.00
PANACEABIO.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1764850000.00
PANACEABIO.NS income_statement (annual, 2024-03-31) — Write Off: 5430000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 1699900000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 630200000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 32800000.00
PANACEABIO.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 62337662.00
PANACEABIO.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.77
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 61300000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 476700000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2024400000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 61300000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 8329100000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 842200000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 5037700000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 0.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 0.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 3278100000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 351800000.00
PANACEABIO.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 62337662.00
PANACEABIO.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.77
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 350500000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 6300800000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1668200000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 8544800000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 159500000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 32800000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 215700000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 215700000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 284200000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: -39900000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 6300800000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 7978600000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 196000000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 674300000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 982500000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 8267800000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 350500000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 464400000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 163300000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 5458600000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 40600000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1547700000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Payables: 1700400000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 61250746.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 8329100000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 7978600000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 12430800000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 8544800000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 215700000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 8289200000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 4141600000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 7393100000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 863500000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 500000.00
PANACEABIO.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 1759600000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 1019600000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 1634900000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 61081081.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 0.74
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 625500000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 89800000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 89800000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 61081081.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.74
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 45200000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — EBIT: 53700000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — EBITDA: 143500000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 1009400000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 9900000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 9900000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 800000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Net Income: 45200000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 45200000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 44400000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 45200000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 45200000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 44400000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -9900000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -9900000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 115800000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 25810000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Operating Income: -10200000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 1634900000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 36200000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 500000000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 43800000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 625500000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 89800000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 27700000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 8310000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Tax Provision: -600000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.30
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 1645100000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 27700000.00
PANACEABIO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 27700000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — +Operating Expense: 4202700000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1157500000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — +Total Revenue: 5590900000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 1325300000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2257560000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2257560000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 725570000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 725570000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -6879090000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6879090000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1941740000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1941740000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -50560000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -50560000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Amortization: 24210000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 24210000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 29950000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 29950000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 61094891.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 60967742.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Basic EPS: -1.37
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.31
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 471700000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 3155040000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 3155040000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -503100000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 61250000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 61250000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 821250000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 821250000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1538350000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1538350000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 309400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 309400000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 511850000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 511850000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -357400000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -658400000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -85900000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 349500000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Common Stock: 61250000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 61250000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 8347860000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 8347860000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 974130000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 974130000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 1995400000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 520800000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Current Assets: 5451790000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 5451790000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 80000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 80000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 3669930000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3669930000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 363500000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 363500000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Depreciation: 348100000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 348100000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 348100000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 84200000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 348100000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 84200000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 61094891.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 60967742.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Diluted EPS: -1.37
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.31
PANACEABIO.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -83700000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -18900000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 0.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — EBIT: -40700000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — EBIT: 10000000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — EBITDA: 307400000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — EBITDA: 94200000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 100000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — End Cash Position: 821300000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 700000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 700000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -26600000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 693050000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 693050000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -776800000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -24500000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -4500000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 326980000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 422620000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 422620000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 776130000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 776130000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 13287130000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 13287130000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Gross Profit: 3595500000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 804500000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 13950000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Interest Expense: 38800000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 10400000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 38800000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 10400000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Interest Income: 77080000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 77080000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -26600000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 77100000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Inventory: 2136710000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2136710000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 8497860000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8497860000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 649800000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 157970000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 157970000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 30650000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 30650000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 2533840000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 2533840000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 150000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 150000000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 150000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 150000000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: 0.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 353400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 353400000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 6624120000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 6624120000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Minority Interest: -41700000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: -41700000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Minority Interests: 3500000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 1000000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 7600000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Net Income: -83700000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Net Income: -18900000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -83700000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -18900000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -87200000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -19900000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -83700000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -18900000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -83700000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -18900000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -79500000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -87200000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -19900000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Net Interest Income: -38800000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -10400000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 1051700000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 0.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -38800000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -10400000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 18300000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Net PPE: 6408040000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 6408040000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -497300000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 0.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 7925240000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 7925240000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 108520000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 108520000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 232820000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 232820000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 426390000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 426390000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: -52500000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -182900000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Normalized Income: -335630000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -212870000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -273700000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Operating Income: -607200000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Operating Income: -353000000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Operating Revenue: 5590900000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 1325300000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 772600000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 772600000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 46640000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 46640000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 216540000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 216540000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 422620000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 422620000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -452600000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 352300000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 352300000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 108500000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 108500000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 206600000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 85900000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 2124100000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 582000000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Payable: 6060000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 6060000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Properties: 5433900000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 5433900000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 37250000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 37250000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 717100000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 717100000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Other Special Charges: -359900000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: -277100000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Payables: 2263620000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Payables: 2263620000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 363600000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 363600000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Preferred Securities Outside Stock Equity: 72060000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 72060000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 765490000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 765490000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Pretax Income: -79500000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -400000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 12500000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -2164200000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -503100000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1274260000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1274260000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1995400000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 520800000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 348100000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 84200000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 47770000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 47770000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: 0.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 248420000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 248420000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 7799130000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 7799130000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 3215900000.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 5800000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 369380000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 696360000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 61250746.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 61250746.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 0.00
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: 0.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Special Income Charges: 359900000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 277100000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 8347860000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 8347860000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 7925240000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 7925240000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 107970000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 83130000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Tax Provision: 7700000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 19500000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
PANACEABIO.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -9600000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 12897460000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 12897460000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 8497860000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 8497860000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 150000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 150000000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 8306160000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8306160000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Total Expenses: 6198100000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1678300000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4591300000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4591300000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 7445670000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7445670000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 921370000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 921370000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 9540000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 100000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 100000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 359900000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 277100000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 359900000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 277100000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 169400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 169400000.00
PANACEABIO.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1781860000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1781860000.00
PANACEABIO.NS income_statement (annual, 2025-03-31) — Write Off: 790000.00
PANACEABIO.NS income_statement (quarterly, 2025-03-31) — Write Off: 0.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 990500000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1667000000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 61363636.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.66
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 772200000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 83900000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 83900000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 61363636.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.66
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 40500000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — EBIT: 74200000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — EBITDA: 158100000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 894800000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 8600000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 8600000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 900000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Net Income: 40500000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 40500000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 39600000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 40500000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 40500000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 39600000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -8600000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -8600000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 44900000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -27834146.34
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Operating Income: -95700000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1667000000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 56700000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 449400000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Other Special Charges: -113200000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 65600000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 772200000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 83900000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 113200000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 44865853.66
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 26000000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.40
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1762700000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 113200000.00
PANACEABIO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 113200000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1083200000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 1411300000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1852900000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 762200000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 66700000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 61321586.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -2.27
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 61300000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 636700000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1283500000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 61300000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 8264100000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1098300000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 589400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 5329800000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 0.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 0.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3450800000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 83400000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 83400000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 61321586.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -2.27
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -139200000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — EBIT: -170300000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — EBITDA: -86900000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 455400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 6426800000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 821900000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 21400000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 21400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1953300000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8493100000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 156500000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 66700000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 229000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 229000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 379800000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: -43500000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 900000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Net Income: -139200000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -139200000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -140100000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -139200000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -139200000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -140100000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -21400000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -21400000.00